Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

NCT03460873 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03460873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03460873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
September 30, 2015
Completion date
November 28, 2019
Enrollment
432 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia (bph)